New CFO at WuXi PharmaTech
This article was originally published in Scrip
The China-based contract research organisation WuXi PharmaTech has named Edward Hu chief financial officer. He has served as chief operating officer since January 2008 and was previously acting CFO from February 2009 to May 2010. Hao Zhou, the company's current CFO, is leaving the company. Charles River Laboratories recently conceded to shareholder pressure and terminated its acquisition of WuXi, paying the CRO a $30 million break-up fee (scripintelligence.com, 30 July 2010).